Leprosy Treatment Market Opportunity Analysis, 2018-2026
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/128
Leprosy Treatment Market Outlook
According to the statistics received by the World Health Organization (WHO), from various regions (138 countries), the number of registered cases of leprosy was 176,176 in 2015, that is 0.18 cases per 10 000 people. The number of new cases shows the degree of sustained transmission of the disease. Global statistics illustrate that 203,600 (96%) of fresh leprosy cases were from 22 key countries. Prevalence of high occurrences is a reminder that some areas around the world show high incidences of the disease and experience very high rate of transmission. According to WHO, around 16 million cases of leprosy have been treated in the last two decades. Governing bodies and governments alike are trying to eradicate the presence of the disease on a global scale. Owing to these factors, the leprosy treatment market is expected to grow at substantial rate over the forecast period (2016–2024).
As per National Leprosy Eradication Programme (NLEP), leprosy has been broadly categorized into two segments namely, paucibacillary leprosy (one to five skin lesions, maximum one nerve with skin liaisons) and multibacillary leprosy (over six skin liaisons, more than one nerve with skin liaisons). Early detection of the disease is an important factor for effective treatment, though various drugs are available for late stage leprosy patients. The most common treatment is multidrug therapy. The drugs recommended by WHO multidrug therapy are rifampicin, dapsone, and clofazimine. Among these, rifampicin is most preferred for treatment of leprosy. Treatment with everyday dapsone and monthly treatment with rifampicin for six months is followed for paucibacillary (PB or tuberculoid) cases. For multibacillary (MB or lepromatous) cases, the treatment is a prolonged one. It includes daily dapsone and clofazimine. Additionally, monthly rifampicin is recommended for 12 months. Side effects, resistance, and relapse rate are low in multidrug therapy. Some of the other drugs available for leprosy treatment are Rifadine and Rimactane. The leprosy treatment market is projected to witness a steep incline in the number of novel drugs and availability of the same, due to increasing initiatives across the globe to eradicate this menace.
Leprosy Treatment Market Future Outlook: Asia Pacific to be Key Growth Market
Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale. Some of them subsidized the treatment to eradicate the presence of the disease from their countries. Therefore government regulation as well as adoption remains the most important driver of the leprosy treatment market.
Asia Pacific, especially India remains one of the most affected countries. As per the World Health Organization reports, about 59% of the new cases reported were from India. According to stats released by the Leprosy Mission Trust, around 127,000 new occurrences of leprosy were reported from India alone during 2013–2014. Out of these, about 46% were women and children. In India, the prevalence rate according to The Leprosy Mission Trust in the year 2014 was about 0.68 per 10,000 population. The National Leprosy Eradication Programme (NLEP) is one such initiative by the Indian government that aims to eradicate the disease from the country by 2018. Therefore, leprosy treatment market in this region is projected to grow at a considerable rate in the near future.
Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/128
Key Players in Leprosy Treatment Market
Companies operating in the leprosy treatment market include Glaxo Smithcline Pharmaceuticals Ltd., Systopic Laboratories Pvt. Ltd., Acme Pharmaceuticals, Cadila Pharmaceuticals, Macleods Pharmaceuticals, IDPL, Astra Zeneca Pharma India Ltd., Lark Laboratories (UIndia) Ltd., Genetic Pharma, and Novartis International AG.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leprosy Treatment Market Opportunity Analysis, 2018-2026 here
News-ID: 1210017 • Views: 275
More Releases from Coherent Market Insights
Autonomous Car Market To Witness A Tremendous Growth With A CAGR of 41.4% by 203 …
In terms of value, the worldwide autonomous car market is predicted to reach US$ 0.6 billion in 2025, with a CAGR of 47.5 % between 2025 and 2035. For business strategists, Autonomous Car Market Research Report 2022-2035 is a great source of relevant data. It includes an overview of the industry, as well as growth analyses, market trends, drivers, and restraints. The research analysts give a detailed overview of the value
Data Center Virtualization Market Report Cover Major Application, Key Insights, …
Data center virtualization is the process of designing, developing and deploying a data center on virtualization and cloud computing technologies. Data center virtualization encompasses a broad range of tools, technologies and processes that enable a data center to operate and provide services on top of virtualization layer/technology. Using data center virtualization, an existing or a standard data center facility can be used to provide/host multiple virtualized data centers on the
Machine to Machine (M2M) Connections Market Key Opportunities, Envelope Growth F …
𝑳𝒂𝒕𝒆𝒔𝒕 𝑼𝒑𝒅𝒂𝒕𝒆𝒔 𝒐𝒏 𝑴𝒂𝒄𝒉𝒊𝒏𝒆 𝒕𝒐 𝑴𝒂𝒄𝒉𝒊𝒏𝒆 (𝑴2𝑴) 𝑪𝒐𝒏𝒏𝒆𝒄𝒕𝒊𝒐𝒏𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝑷𝒆𝒓𝒔𝒑𝒆𝒄𝒕𝒊𝒗𝒆 𝒘𝒊𝒕𝒉 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑫𝒂𝒕𝒂 𝒂𝒏𝒅 𝑩𝒖𝒔𝒊𝒏𝒆𝒔𝒔 𝑶𝒖𝒕𝒍𝒐𝒐𝒌 2022 𝒕𝒐 2027 The Machine to Machine (M2M) Connections market study entails a thorough examination of the several factors that contribute to the market's expansion. It includes market growth potential, drivers, restraints, industry-specific challenges and risks, and opportunities that could have a negative or positive impact on the market. This research report focuses on various
Online Hyperlocal Services Market Value, Volume, CAGR, Future Opportunities, and …
The global online hyperlocal services market is estimated to exhibit a CAGR of 32.6% over the forecast period. The Online Hyperlocal Services market research includes a detailed examination of the many elements that drive the market's growth. It contains growth potential, drivers, restrictions, industry-specific difficulties and hazards, and opportunities that could negatively or positively impact the market. The recently released report by Online Hyperlocal Services Market Research analyze the market
More Releases for Leprosy
Leprosy Treatment Market to Reap Excessive Revenues by 2028(Based on drug class …
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Leprosy is also known as Hansen’s disease. It affects the skin, mucosal surfaces of the upper respiratory tract, the peripheral nerves and the eyes. Leprosy can occur in people of all ages, from infants to the elderly. The exact transmission of the disease is not known, but it is strongly believed that leprosy is transferred from a leprosy patient to
Global Leprosy Treatment Market Industry Trend and Forecast 2025
This report focuses on the global Leprosy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leprosy Treatment development in United States, Europe and China. Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis. Initially, infections are without symptoms and typically remain this way for 5 to 20 years. Symptoms that develop
Leprosy Treatment Market Positive long-term growth outlook 2018-2026
Leprosy Treatment Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Leprosy Treatment market research report is a professional and in-depth study on the current state of Leprosy Treatment Industry. The Leprosy Treatment Market research report covers the present scenario and the growth prospects of
Leprosy Vaccines Market Promising Growth Opportunities over 2018 to 2028
Leprosy is chronic infectious disease caused by Mycobacterium leprae. Leprosy is also referred to as Hansen’s disease. Leprosy affects the skin, mucosal surfaces of the upper respiratory tract, the peripheral nerves and the eyes. Leprosy can occur to the people of all ages from infant to geriatric. The exact reason for transmission of leprosy is not known but it is strongly believed that leprosy is transferred from a leprosy patient
Leprosy Treatment Market Research Report by Regional Analysis : forecast 2024
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk
Leprosy Treatment Market - Global industry analysis and forecast 2016-2024
Leprosy Treatment Market Future Outlook: Asia Pacific to be Key Growth Market Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale.